Enterprises are transforming into AI-native entities by embedding AI into their core operations, moving beyond predictive ...

North Carolina-based biotech Tune Therapeutics has raised $175 million in a Series B that will help it to take its lead epigenetic silencing drug, Tune-401, into clinical testing as a potential ...

He is the head of HHS, and yet he continues to spout untested, unproven therapies and has only given a very lukewarm ...

Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.

Attovia Therapeutics has completed an oversubscribed $90 million Series C financing, which the company plans to use along with existing cash and investments to advance its two lead pipeline candidates ...

Spruce Biosciences has put out new shoots, snapping up rights to a former BioMarin rare disease candidate and outlining plans ...

PolyAI, a leading provider of AI agents for enterprise customer service, today announced the launch of its latest version of Agent Studio, the world's only voice-first omnichannel platform for ...

Snowflake , the AI Data Cloud company, in collaboration with Enterprise Strategy Group, today released the "Radical ROI of Generative AI," a global research report surveying 1,900 business and IT ...

Verve Therapeutics (NASDAQ: VERV) stock is seeing explosive gains Tuesday. The biotech company's share price was up 24.5% as of 12:30 p.m. ET and had been up as much as 41% earlier in the session.

Check out how to watch Leeds United v Stoke City in the Championship, including TV channel, live stream coverage and kick-off ...

WALTHAM, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on advancing life-transforming therapeutics for people living with ...